Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Silent ischaemia in the 1990s.

D Tzivoni1

  • 1Bikur Cholim Hospital, Jerusalem, Israel.

Drugs
|January 1, 1991
PubMed
Summary

Silent myocardial ischemia, characterized by ST depression without chest pain, carries the same prognosis as symptomatic ischemia. Preventing ischemic episodes, silent or not, is crucial as disease severity dictates intervention needs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardioversion-induced fulminant ischaemic hepatitis.

European journal of gastroenterology & hepatology·2001
Same author

Incidence of immunoglobulin G antibodies to Chlamydia pneumoniae in acute myocardial infarction patients.

The Israel Medical Association journal : IMAJ·2001
Same author

Value and limitations of ambulatory ECG monitoring for assessment of myocardial ischemia.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2001
Same author

Drug-induced QT prolongation.

The Israel Medical Association journal : IMAJ·2001
Same author

Silent myocardial ischemia: an update.

The Israel Medical Association journal : IMAJ·2001
Same author

End organ protection by calcium-channel blockers.

Clinical cardiology·2001

Area of Science:

  • Cardiology
  • Ischemic Heart Disease

Background:

  • Silent myocardial ischemia is common in coronary heart disease and can cause permanent myocardial changes.
  • The physiological manifestations of silent ischemia mirror those of symptomatic ischemia.

Purpose of the Study:

  • To evaluate the prognostic significance of silent versus symptomatic myocardial ischemia.
  • To determine the most effective methods for assessing coronary artery disease severity and guiding treatment.

Main Methods:

  • Exercise testing, often combined with radionuclide scintigraphy or ventriculography, is the preferred method for assessing coronary artery disease severity.
  • Ambulatory ECG monitoring may be less sensitive than exercise provocation for detecting ischemia.

Main Results:

  • The prognosis for patients with myocardial ischemia is similar, regardless of whether it is silent or symptomatic.
  • Ischemic episodes, irrespective of symptoms, are a stronger predictor of adverse outcomes than left ventricular function or coronary artery disease extent.
  • Both anti-ischemic medications (beta-blockers, calcium antagonists, nitrates) and interventions (angioplasty, bypass surgery) are effective treatments.

Conclusions:

  • The presence or absence of symptoms does not alter the prognostic impact of myocardial ischemia.
  • Disease severity, not symptoms, should guide the need for intervention in patients with coronary heart disease.
  • Preventing all ischemic episodes, silent or symptomatic, is paramount for improving patient outcomes.

Related Experiment Videos